Presenilin-1 protein expression in familial and sporadic Alzheimer's disease

Annals of Neurology

Volumn 41, Issue 6, 1997, Pages 742-753

  Levey, Allan I ^a   Heilman, Craig J ^a   Lah, James J ^a   Nash, Norman R ^a   Rees, Howard D ^a   Wakai, Masakazu ^a   Mirra, Suzanne S ^b   Rye, David B ^a   Nochlin, David ^c   Bird, Thomas D ^d   Mufson, Elliott J ^e  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MONOCLONAL ANTIBODY; POLYPEPTIDE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BIOPSY; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MISSENSE MUTATION; NEUROFIBRILLARY TANGLE; ONSET AGE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; SENILE PLAQUE;

ADULT; AGED; ALZHEIMER DISEASE; ANIMALS; BLOTTING, WESTERN; BRAIN; HAPLORHINI; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MIDDLE AGED; PC12 CELLS; PRESENILIN-1; RATS; TISSUE DISTRIBUTION; TRANSFECTION;

EID: 15444350008     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410410610     Document Type: Article

References (50)

1. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472
2. Barclay L, Zemcov A, Blass J, et al. Factors associated with duration of survival in Alzheimer's disease. Biol Psych 1985;20: 86-93
3. Heyman A, Wilkinson WE, Hurwitz BJ, et al. Early-onset Alzheimer's disease: clinical predictors of institutionalization and death. Neurology 1987;37:980-984
4. Jacobs D, Sano M, Marder K, et al. Age at onset of Alzheimer's disease: relation to pattern of cognitive dysfunction and rate of decline. Neurology 1994;44:1215-1220
5. Koss E, Edland S, Fillenbaum G, et al. Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer's disease: a CERAD analysis, part XII. Neurology 1996;46:136-141
6. Haltia M, Viitanen M, Sulkava R, et al. Chromosome 14-encoded Alzheimer's disease: genetic and clinicopathological description. Ann Neurol 1994;36:362-367
7. Lampe T, Bird T, Nochlin D, et al. Phenotype of chromosome 14-linked familial Alzheimer's disease in a large kindred. Ann Neurol 1994;36:368-378
8. Murrell J, Farlow M, Ghetti B, et al. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 1991;254:97-99
9. Goate A, Chartier-Harlin MC, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991;349:704-706
10. Chartier-Harlin MC, Crawford F, Houlden H, et al. Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature 1991;353: 844-846
11. Sherrington R, Rogaev E, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995;375:754-760
12. Sorbi S, Nacmias B, Forleo P, et al. Missense mutation of S182 gene in Italian families with early-onset Alzheimer's disease. Lancet 1995;346:439-440
13. Wasco W, Pettingell W, Jondro P, et al. Familial Alzheimer's chromosome 14 mutations. Nat Med 1995;1:848
14. Clark R, Hutton M, Fuldner F, et al. The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nat Genet 1995;11:219-222
15. Broeckhoven CV. Presenilins and Alzheimer disease. Nat Genet 1995;11:230-232
16. Rogaev E, Sherrington R, Rogaeva E, et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995;376:775-778
17. Levy-Lahad E, Wasco W, Poorkaj P, et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995;269:973-977
18. Tanahashi H, Mitsunaga Y, Takahashi K, et al. Missense mutation of S182 gene in Japanese familial Alzheimer's disease. Lancet 1995;346:440
19. Perez-Tur J, Froelich S, Prihar G, et al. A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene. Neuroreport 1995;7:297-301
20. Levy-Lahad E, Wijsman E, Nemens E, et al. A familial Alzheimer's disease locus on chromosome 1. Science 1995;269:970-973
21. L'Hernault S, Arduengo P. Mutation of a putative sperm membrane protein in Caenorhabditis elegans prevents sperm differentiation but not its associated meiotic divisions. J Cell Biol 1992; 119:55-68
22. Levitan D, Greenwald I. Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 1995;377:351-354
23. Kovacs D, Fausett H, Page K, et al. Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nat Med 1996; 2:224-229
24. Lah J, Heilman C, Nash N, et al. Light and electron microscopic localization ot presenilin-1 in primate brain. J Neurosci (in press)
25. Levey A, Kitt C, Simonds W, et al. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J Neurosci 1991;11:3218-3226
26. Kim K, Miller D, Sapienza V, et al. Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci Res Commun 1988;2:121-130
27. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486
28. Bird TD, Lampe TH, Nemens EJ, et al. Familial Alzheimer's disease in American descendants of the Volga Germans: probable genetic founder effect. Ann Neurol 1988;23:25-31
29. Bird TD, Sumi SM, Nemens EJ, et al. Phenotypic heterogeneity in familial Alzheimer's disease: a study of 24 kindreds. Ann Neurol 1989;25:12-25
30. Thinakaran G, Borchelt D, Lee M, et al. Endoproteolysis of presenilin 1 and regulated accumulation of processed derivatives in vivo. Neuron 1996;17:181-190
31. Flynn D, Ferrari-DiLeo G, Mash D, et al. Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease. J Neurochem 1995;64:1888-1891
32. Benzing W, Mufson E. Apolipoprotein E immunoreactivity within neurofibrillary tangles: relationship to tau and PHF in Alzheimer's disease. Exp Neurol 1995;132:162-171
33. Mercken M, Takahashi H, Honda T, et al. Characterization of human presenilin 1 using N-terminal specific monoclonal antibodies: evidence that Alzheimer mutations affect proteolytic processing. FEBS Lett 1996;389:297-303
34. Mizusawa H, Yen S-H, Hirano A, et al. Pathology of the dentate nucleus in progressive supranuclear palsy: a histological, immunohistochemical and ultrastructural study. Acta Neuropathol (Berl) 1989;78:419-428
35. Cribbs D, Chen L, Bende S, et al. Widespread neuronal expression of the presenilin-1 early-onset Alzheimer's disease gene in the murine brain. Am J Pathol 1996;148:1797-1806
36. Suzuki T, Nishiyama K, Murayama S, et al. Regional and cellular presenilin 1 gene expression in human and rat tissues. Biochem Biophys Res Commun 1996;219:708-713
37. Cook D, Sung J, Golde T, et al. Expression and analysis of presenilin 1 in a human neuronal system: localization in cell bodies and dendrites. Proc Natl Acad Sci USA 1996;93:9223-9228
38. Wisniewski T, Palha J, Ghiso J, et al. S182 protein in Alzheimer's disease neuritic plaques. Lancet 1995;346:1366
39. Bouras C, Giannakopoulos P, Schioi J, et al. Presenilin-1 polymorphism and Alzheimer's disease. Lancet 1996;347:1185-1186 (Letter)
40. Lemere C, Lopera F, Kosik K, et al. The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology. Nat Med 1996;2:1146-1150
41. Mann D, Iwatsubo T, Cairns N, et al. Amyloid βprotein (Aβ) deposition in chromosome 14-linked Alzheimer's disease: predominance of Aβ42(43). Ann Neurol 1996;40:149-156
42. Borchelt D, Thinakaran G, Eckman C, et al. Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo. Neuron 1996;17:1005-1013
43. Scheuner D, Eckman C, Jensen M, et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 1996;2:864-870
44. Selkoe DJ. The molecular pathology of Alzheimer's disease. Neuron 1991;6:487-498
45. Kosik K, Greenberg S. Tau protein and Alzheimer disease. In: Terry R, Katzman R, Bick K, eds. Alzheimer disease. New York: Raven, 1994:335-344
46. Strittmatter WJ, Weisgraber KH, Goedert M, et al. Hypothesis: microtubule instability and paired helical filament formation in Alzheimer's disease brain are related to apolipoprotein E geno-type. Exp Neurol 1994;125:163-171
47. Wragg M, Hutton M, Talbot C, et al. Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Lancet 1996;347:509-512
48. Kehoe P, Williams J, Lovestone S, et al. Presenilin-1 polymorphism and Alzheimer's disease. Lancet 1996;347:1185 (Letter)
49. Higuchi S, Muramatsu T, Matsushita S, et al. Presenilin-1 polymorphism and Alzheimer's disease. Lancet 1996;347:1186 (Letter)
50. Scott W, Growdon J, Roses A, et al. Presenilin-1 polymorphism and Alzheimer's disease. Lancet 1996;347:1186-1187 (Letter)